EP Patent

EP3345898B1 — Crystals of 5-cyclopropyl-2-((1-(3-fluorobenzyl)-1h-indol-5-yl)amino)nicotinic acid

Assigned to Fujifilm Corp · Expires 2020-05-06 · 6y expired

What this patent protects

Patent listed against Lytgobi.

Drugs covered by this patent

Patent Metadata

Patent number
EP3345898B1
Jurisdiction
EP
Classification
—
Expires
2020-05-06
Drug substance claim
No
Drug product claim
No
Assignee
Fujifilm Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.